Literature DB >> 28617918

Intravitreal Melphalan for Treatment of Primary Vitreoretinal Lymphoma: A New Indication for an Old Drug.

Carol L Shields1, Kareem Sioufi1, Arman Mashayekhi1, Jerry A Shields1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28617918     DOI： 10.1001/jamaophthalmol.2017.1810

Source DB:  PubMed          Journal:  JAMA Ophthalmol        ISSN： 2168-6165            Impact factor:   7.389


× No keyword cloud information.
  3 in total

1.  Intravitreous Cutaneous Metastatic Melanoma in the Era of Checkpoint Inhibition: Unmasking and Masquerading.

Authors:  Jasmine H Francis; Duncan Berry; David H Abramson; Christopher A Barker; Chris Bergstrom; Hakan Demirci; Michael Engelbert; Hans Grossniklaus; Baker Hubbard; Codrin E Iacob; Korey Jaben; Madhavi Kurli; Michael A Postow; Jedd D Wolchok; Ivana K Kim; Jill R Wells
Journal:  Ophthalmology       Date:  2019-09-24       Impact factor: 12.079

2.  Successful treatment of ciliary body medulloepithelioma with intraocular melphalan chemotherapy: a case report.

Authors:  Christina Stathopoulos; Marie-Claire Gaillard; Julie Schneider; Francis L Munier
Journal:  BMC Ophthalmol       Date:  2020-06-18       Impact factor: 2.209

3.  Insights from a Case of Vitreoretinal Lymphoma.

Authors:  Bertil E Damato; Gregory J Bever; Armin R Afshar; James L Rubenstein
Journal:  Ocul Oncol Pathol       Date:  2018-04-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.